SCHEMBL23009248

SCHEMBL23009248

O=C1CCC(=O)N1Cc1ccco1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.63
HTT P42858 1/20 0.63
MAPT P10636 5/20 0.61
MEN1 O00255 4/20 0.61
POLB P06746 4/20 0.61
KMT2A Q03164 4/20 0.61
HSD17B10 Q99714 3/20 0.61
APEX1 P27695 2/20 0.61
RECQL P46063 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
PSMD14 O00487 1/20 0.61
MMP2 P08253 1/20 0.61
DNMT1 P26358 1/20 0.61
PTPN7 P35236 1/20 0.61
HBB P68871 1/20 0.61
KDM4C Q9H3R0 1/20 0.61
USP2 O75604 4/20 0.60
HPGD P15428 2/20 0.60
ALOX12 P18054 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11157478 0.88 MAPT (0.61) KDM4EHTTMAPTMEN1POLB
SCHEMBL17525779 0.79 KDM4E (0.53) KDM4EHTTMAPTMEN1POLB
SCHEMBL2795967 0.78 ALDH1A1 (0.54) KDM4EMAPTMEN1POLBKMT2A
SCHEMBL2115613 0.76 MAPT (1.00) KDM4EHTTMAPTMEN1POLB
SCHEMBL480278 0.76 ALDH1A1 (0.73) KDM4EMAPTMEN1POLBKMT2A
SCHEMBL5912905 0.75 L3MBTL1 (0.49) KDM4EHTTMAPTMEN1POLB
SCHEMBL6805692 0.75 TSHR (0.49) KDM4EHTTMAPTMEN1POLB
SCHEMBL5728014 0.75 GSK3A (0.59) KDM4EHTTMAPTMEN1POLB
SCHEMBL11791001 0.74 ALDH1A1 (0.54) KDM4EHTTMAPTMEN1POLB
SCHEMBL16277156 0.74 SIGMAR1 (0.50) KDM4EMEN1KMT2ATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210047282-A1 REVERSIBLE CROSSLINKING REACTANT COMPOSITION INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2021-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210047282-A1 REVERSIBLE CROSSLINKING REACTANT COMPOSITION RRS1, CCNE2, RPS9 KDM4E 280/4885HTT 2658/4885MAPT 2633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.